secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K
Filed at:   2024-04-25T23:59:59+00:00
Accession:  0000920148-24-000029
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp Q1 adj EPS $3.68 vs $3.46 YoY; raises FY guidance midpoint
------------------------------------------------------------------

- Revenue $3.18B (+4.6% YoY); organic base business grew 6.7%.
- Diluted EPS $2.69 vs $2.34; adjusted EPS $3.68 vs $3.46.
- FY2024 adjusted EPS guidance raised to $14.45-$15.35 (prev $14.30-$15.40); FCF reaffirmed $1.0-$1.15B.
- Acquisitions: selected Invitae assets, agreed to buy BioReference Health diagnostic assets, closed three deals including Baystate Health and Providence.
- New holding company structure May 17; Labcorp Holdings Inc. replaces Labcorp as public entity; ticker LH unchanged; $0.72 dividend payable June 12.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014824000029/0000920148-24-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014824000029/lh-20240425.htm
  HTML page:      https://secwatch.observer/filing/0000920148-24-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer